Related Attributes
Product details
Morpholine ethyl mycophenolate is an immunosuppressant used in organ transplantation and is also used to treat autoimmune myasthenia gravis (MG).
Uses of Mycophenolate Mofetil.
It is mainly used to prevent allogeneic organ rejection. It is mainly used for kidney transplantation, but also for heart and liver transplantation, especially for refractory rejection after transplantation. It can be used simultaneously with cyclosporine and corticosteroids. It can also be used in rheumatoid arthritis, systemic lupus erythematosus, primary glomerulonephritis, psoriasis and other autoimmune diseases. Oral: Kidney transplantation: the initial dose is 2 to 3mg/kg per day, and the maintenance dose is 1 to 2mg/kg per day, divided into 2 to 3 times. Can be adjusted according to the condition.
In vitro study of Mycophenolate Mofetil.
Mycophenolatemofetil is an ester prodrug of mycophenolic acid (MPA), an active immunosuppressive agent. The latter showed non-competitive, selective and reversible inhibitory activity against type I/II hypoxylglycinate dehydrogenase with IC50 of 39nM and 27nM, respectively. In addition, MPA also produced concentration-dependent inhibition of CONA-stimulated T cell proliferation, LPS-stimulated B cell proliferation, and isoantigen-specific T cell proliferation with IC50 of 100nM, 120nM, and 51nM, respectively. Mycophenolatemofetil induced strong apoptosis of microglia cultures at a high concentration of 10μg/mL and increased the number of activated caspase-3 immunoreactive apoptotic cells. In addition, Mycophenolatemofetil(1μg/mL) strongly inhibited the proliferation of microglia and astrocytes. A recent study showed that Mycophenolatemofetil time-dependent significantly reduced the degree of neuronal cell death in organotype hippocampal section cultures after neuronal injury.
Product method of Bulk Mycophenolate Mofetil Powder.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,